Related Experiment Video
Updated: Jun 27, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
Do nomograms predict aggressive recurrence after radical prostatectomy more accurately than biochemical recurrence
Florian R Schroeck1, William J Aronson, Joseph C Presti
1Division of Urologic Surgery, Department of Surgery, and Duke Prostate Center, Duke University Medical Center, Durham, NC 27710, USA.
Predicting aggressive recurrence after prostatectomy is more accurate than predicting biochemical recurrence alone. Current models better assess cancer biology, improving aggressive recurrence prediction. All models showed similar accuracy for aggressive recurrence.
Area of Science:
- Urology
- Oncology
- Medical Statistics
Background:
- Biochemical recurrence (BCR) after radical prostatectomy (RP) is a common outcome.
- Predicting aggressive recurrence, defined by a short prostate-specific antigen (PSA) doubling time (DT), is crucial for guiding treatment decisions.
- Existing risk stratification models aim to predict these outcomes, but their comparative accuracy requires evaluation.
Purpose of the Study:
- To compare the predictive accuracy (PA) of nine established risk stratification models.
- To assess model performance in predicting biochemical recurrence (BCR) versus aggressive recurrence (BCR with PSA doubling time <9 months) post-RP.
- To determine if model accuracy differs between preoperative and postoperative risk assessments.
Main Methods:
- A cohort of 1550 men undergoing RP between 1988 and 2007 was analyzed.
- Nine distinct risk stratification models were evaluated for their ability to predict BCR and aggressive recurrence.
- Predictive accuracy was quantified using the concordance index (c-statistic).
Main Results:
- The 10-year risks for BCR and aggressive recurrence were 47% and 9%, respectively.
- All nine models demonstrated higher PA for predicting aggressive recurrence (mean c=0.756) compared to BCR alone (mean c=0.702), with a mean difference of 0.054.
- This improvement in PA was more pronounced for preoperative models than postoperative models (0.053 vs 0.036, P=0.03).
- Sensitivity analyses using varying definitions for aggressive recurrence (PSA DT <6 or <12 months) yielded similar results.
Conclusions:
- Existing risk models offer superior predictive accuracy for aggressive recurrence compared to BCR alone after RP.
- The enhanced prediction of aggressive recurrence likely stems from models' focus on cancer biology, which correlates more strongly with aggressive disease.
- While all tested models showed comparable accuracy for predicting aggressive recurrence, their performance in this specific prediction is noteworthy.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025